Pulse Biosciences Investor Relations Material
Latest events
Q1 2024
Pulse Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Pulse Biosciences Inc
Access all reports
Pulse Biosciences, Inc. (Pulse) is a novel bioelectric medicine company. The Company focuses on the development of its product candidate, the NBE chip, which provides real-time localized electrocardiogram (ECG) data in an ambulatory setting. Pulse's proprietary technology utilizes predefined algorithms to provide analysis and measurement features to improve clinical outcomes following a procedure at the point of care.
Key slides for Pulse Biosciences Inc
Investor Presentation
Pulse Biosciences Inc
Investor Presentation
Pulse Biosciences Inc
Latest articles
From Timber to Luxury: The Story of François-Henri Pinault and Kering
Dive into the story of François-Henri Pinault, from his rise in the family timber business to leading Kering into a global luxury powerhouse.
7 May 2024
Companies That Had Their IPO in 1994: A Cautious Market
An overview of the year 1994 in the stock and IPO market, as the interest rates soared and the bond market collapsed.
6 May 2024
The World of Luxury: Creating and Selling Desirability
Dive into the enchanting world of high-end allure, where the art of exclusivity shapes desire, turning luxury into an emblem of unique prestige.
6 May 2024
Ticker symbol
Country
🇺🇸 United States